Cargando…

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma

BACKGROUND: Nasopharyngeal carcinoma is an Epstein-Barr virus (EBV)-associated tumor that is highly common in southern China. Our previous sequencing data demonstrated that the EBV-encoded microRNA BART8-3p was most upregulated in nasopharyngeal carcinoma (NPC) and was closely associated with the me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Cheng, Lin, Keyu, Zhang, Bin, Su, Ying, Guo, Qiaojuan, Lu, Tianzhu, Xu, Yuanji, Lin, Shaojun, Zong, Jingfeng, Pan, Jianji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Head and Neck Cancers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982379/ https://www.ncbi.nlm.nih.gov/pubmed/35380720 http://dx.doi.org/10.1093/oncolo/oyac024

Ejemplares similares

Circulating Epstein‐Barr virus microRNAs BART7‐3p and BART13‐3p as novel biomarkers in nasopharyngeal carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2020)

BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma
por: Wang, Youhong, et al.
Publicado: (2017)

NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma
por: Verhoeven, Rob J. A., et al.
Publicado: (2016)

Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study
por: Xu, Yuanji, et al.
Publicado: (2017)

EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
por: Lin, Cheng, et al.
Publicado: (2018)

Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
por: Lin, Cheng, et al.
Publicado: (2019)

Association between variant alleles of major histocompatibility complex class II regulatory genes and nasopharyngeal carcinoma susceptibility
por: Zhou, Ping, et al.
Publicado: (2020)

Meta‐Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
por: Mané, Maïmouna, et al.
Publicado: (2020)

Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Ye, Lulu, et al.
Publicado: (2018)

Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy
por: Lu, Tianzhu, et al.
Publicado: (2016)

The cadherin–catenin complex in nasopharyngeal carcinoma
por: Galera-Ruiz, H., et al.
Publicado: (2011)

Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma
por: Lin, Xiandong, et al.
Publicado: (2021)

The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma
por: Lou, Yunlong, et al.
Publicado: (2022)

Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era
por: Chen, Zhuhong, et al.
Publicado: (2017)

Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
por: Verhoeven, Rob J. A., et al.
Publicado: (2019)

Sonographic assessment of swallowing in irradiated nasopharyngeal carcinoma patients
por: Cheng, Dennis T. H., et al.
Publicado: (2018)

Long-term treatment outcomes of juvenile nasopharyngeal angiofibroma treated with radiotherapy
por: MALLICK, S., et al.
Publicado: (2015)

Clinicopathologic idiosyncrasies of nasopharyngeal cancer in a moderate-risk Mediterranean region
por: Kourelis, K., et al.
Publicado: (2017)

Epstein–Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma
por: Zhang, Ting, et al.
Publicado: (2022)

Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I–II nasopharyngeal carcinoma: a nest case-control study
por: Xiao, Bei-Bei, et al.
Publicado: (2021)

Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site
por: Zhang, Shui-xing, et al.
Publicado: (2014)

Two types of lateral extension in juvenile nasopharyngeal angiofibroma: diagnostic and therapeutic management
por: Szymańska, Anna, et al.
Publicado: (2014)

Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma
por: Mao, Jiaji, et al.
Publicado: (2019)

Comparisons of quality of life for patients with nasopharyngeal carcinoma after treatment with different RT technologies
por: JANG-CHUN, L., et al.
Publicado: (2014)

Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Lyu, Yingchen, et al.
Publicado: (2020)

The role of diagnostic and interventional radiology in juvenile nasopharyngeal angiofibroma: A case report and literature review
por: Suroyo, Indrati, et al.
Publicado: (2020)

Value of skull base invasion subclassification in nasopharyngeal carcinoma: implication for prognostic stratification and use of induction chemotherapy
por: Li, Shuqi, et al.
Publicado: (2022)

Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population
por: Xing, Haijie, et al.
Publicado: (2019)

Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
por: Xu, Yun, et al.
Publicado: (2016)

The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019
por: Yu, Hao, et al.
Publicado: (2021)

Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma
por: Yang, Shan-Shan, et al.
Publicado: (2022)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
por: Zhou, Han, et al.
Publicado: (2020)

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2020)

Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [(18)F]FDG PET/CT parameters
por: Dongxiang, Wen, et al.
Publicado: (2022)

The use of platelet-rich plasma gel in superficial parotidectomy
por: RICCI, E., et al.
Publicado: (2019)

Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma
por: Xu, Yuanji, et al.
Publicado: (2017)

Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma
por: Thierauf, Julia, et al.
Publicado: (2019)

Case report: Nasopharyngeal tuberculosis
por: Prasad, BKD, et al.
Publicado: (2008)

Congenital absence of the internal carotid artery with intercavernous anastomosis
por: Chen, Jesse, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ic34slh52flhogo55qdod8k91p